25 XP   0   0   10

Indoco Remedies Limited
Buy, Hold or Sell?

Let's analyse Indoco together

PenkeI guess you are interested in Indoco Remedies Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Indoco Remedies Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Indoco Remedies Limited

I send you an email if I find something interesting about Indoco Remedies Limited.

Quick analysis of Indoco (30 sec.)










What can you expect buying and holding a share of Indoco? (30 sec.)

How much money do you get?

How much money do you get?
INR0.11
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR111.58
Expected worth in 1 year
INR165.24
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
INR62.65
Return On Investment
19.1%

For what price can you sell your share?

Current Price per Share
INR328.50
Expected price per share
INR315.75 - INR385.10
How sure are you?
50%

1. Valuation of Indoco (5 min.)




Live pricePrice per Share (EOD)

INR328.50

Intrinsic Value Per Share

INR-117.29 - INR11.78

Total Value Per Share

INR-5.71 - INR123.36

2. Growth of Indoco (5 min.)




Is Indoco growing?

Current yearPrevious yearGrowGrow %
How rich?$123.3m$108.5m$14.8m12.0%

How much money is Indoco making?

Current yearPrevious yearGrowGrow %
Making money$17m$18.5m-$1.5m-8.8%
Net Profit Margin8.5%10.0%--

How much money comes from the company's main activities?

3. Financial Health of Indoco (5 min.)




4. Comparing to competitors in the Drugs - Generic industry (5 min.)




  Industry Rankings (Drugs - Generic)  

What can you expect buying and holding a share of Indoco? (5 min.)

Welcome investor! Indoco's management wants to use your money to grow the business. In return you get a share of Indoco.

What can you expect buying and holding a share of Indoco?

First you should know what it really means to hold a share of Indoco. And how you can make/lose money.

Speculation

The Price per Share of Indoco is INR328.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Indoco.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Indoco, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR111.58. Based on the TTM, the Book Value Change Per Share is INR13.41 per quarter. Based on the YOY, the Book Value Change Per Share is INR14.72 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR2.25 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Indoco.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.190.1%0.190.1%0.200.1%0.110.0%0.100.0%
Usd Book Value Change Per Share0.160.0%0.160.0%0.180.1%0.090.0%0.130.0%
Usd Dividend Per Share0.030.0%0.030.0%0.020.0%0.010.0%0.020.0%
Usd Total Gains Per Share0.190.1%0.190.1%0.190.1%0.110.0%0.150.0%
Usd Price Per Share3.91-3.91-4.52-3.37-3.19-
Price to Earnings Ratio21.09-21.09-22.42--98.23--31.88-
Price-to-Total Gains Ratio20.79-20.79-23.22--82.56--26.03-
Price to Book Ratio2.92-2.92-3.84-3.18-3.62-
Price-to-Total Gains Ratio20.79-20.79-23.22--82.56--26.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.942
Number of shares253
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.01
Usd Book Value Change Per Share0.160.09
Usd Total Gains Per Share0.190.11
Gains per Quarter (253 shares)47.5526.69
Gains per Year (253 shares)190.21106.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
127163180149397
25532637027186204
38248956041279311
410965275055372418
513781494068466525
6164977113082559632
71911140132095652739
821813031510109745846
924614661700123838953
10273162918901369311060

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%9.01.00.090.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%9.01.00.090.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%9.01.00.090.0%

Fundamentals of Indoco

About Indoco Remedies Limited

Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform, Sensodent-KF, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastro intestinal products, such as Carmicide, Cyclopam, Carmicide Drops, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and opthalmological products, such as Renolen, Homide, Tobaren DM, and Mofloren-D. It also provides vitamins/minerals/nutrients that include Methycal, MCBM 69, SM Fibro, Durashape, Trucharge, and Apispur; Urology products, such as Cital, Cital UTI, and Cital-H; Cloben-G and Scabex for derma; ATM for anti-invectives; Otorex for otologicals; Obi X and KG-Low for anti-obesity; Hemsyl for blood related; Dexoren for Opthal/Otologicals; and Vepan, bactogard, and Oxipod for anti-infectives. In addition, the company offers PGVISC eye drops; Aziltence for cardiac therapy; and D-Chiro for gynaec therapy. Further, it provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism, compatibility, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Additionally, the company offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. It serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, and nephrologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2024-03-26 11:49:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Indoco Remedies Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Indoco earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Indoco to the Drugs - Generic industry mean.
  • A Net Profit Margin of 8.5% means that ₹0.09 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Indoco Remedies Limited:

  • The MRQ is 8.5%. The company is making a profit. +1
  • The TTM is 8.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.5%TTM8.5%0.0%
TTM8.5%YOY10.0%-1.5%
TTM8.5%5Y5.6%+2.9%
5Y5.6%10Y6.5%-0.9%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ8.5%8.5%+0.0%
TTM8.5%8.5%+0.0%
YOY10.0%9.1%+0.9%
5Y5.6%5.6%0.0%
10Y6.5%5.8%+0.7%
1.1.2. Return on Assets

Shows how efficient Indoco is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Indoco to the Drugs - Generic industry mean.
  • 8.6% Return on Assets means that Indoco generated ₹0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Indoco Remedies Limited:

  • The MRQ is 8.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 8.6%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ8.6%TTM8.6%0.0%
TTM8.6%YOY10.4%-1.8%
TTM8.6%5Y5.5%+3.0%
5Y5.5%10Y6.4%-0.8%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ8.6%8.6%0.0%
TTM8.6%8.6%0.0%
YOY10.4%10.4%+0.0%
5Y5.5%5.5%+0.0%
10Y6.4%6.4%0.0%
1.1.3. Return on Equity

Shows how efficient Indoco is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Indoco to the Drugs - Generic industry mean.
  • 13.8% Return on Equity means Indoco generated ₹0.14 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Indoco Remedies Limited:

  • The MRQ is 13.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.8%TTM13.8%0.0%
TTM13.8%YOY17.1%-3.3%
TTM13.8%5Y9.2%+4.6%
5Y9.2%10Y10.7%-1.5%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ13.8%13.8%+0.0%
TTM13.8%13.8%+0.0%
YOY17.1%17.1%+0.0%
5Y9.2%9.2%+0.0%
10Y10.7%11.4%-0.7%

1.2. Operating Efficiency of Indoco Remedies Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Indoco is operating .

  • Measures how much profit Indoco makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Indoco to the Drugs - Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Indoco Remedies Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y3.9%-3.9%
5Y3.9%10Y7.8%-3.9%
1.2.2. Operating Ratio

Measures how efficient Indoco is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drugs - Generic industry mean).
  • An Operation Ratio of 0.35 means that the operating costs are ₹0.35 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Indoco Remedies Limited:

  • The MRQ is 0.354. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.354. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.354TTM0.3540.000
TTM0.354YOY0.339+0.015
TTM0.3545Y0.731-0.377
5Y0.73110Y1.003-0.272
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3540.567-0.213
TTM0.3540.567-0.213
YOY0.3390.558-0.219
5Y0.7311.087-0.356
10Y1.0031.256-0.253

1.3. Liquidity of Indoco Remedies Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Indoco is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drugs - Generic industry mean).
  • A Current Ratio of 1.90 means the company has ₹1.90 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Indoco Remedies Limited:

  • The MRQ is 1.904. The company is able to pay all its short-term debts. +1
  • The TTM is 1.904. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.904TTM1.9040.000
TTM1.904YOY1.821+0.083
TTM1.9045Y1.538+0.366
5Y1.53810Y1.496+0.042
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9041.715+0.189
TTM1.9041.715+0.189
YOY1.8211.592+0.229
5Y1.5381.381+0.157
10Y1.4961.260+0.236
1.3.2. Quick Ratio

Measures if Indoco is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Indoco to the Drugs - Generic industry mean.
  • A Quick Ratio of 0.86 means the company can pay off ₹0.86 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Indoco Remedies Limited:

  • The MRQ is 0.859. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.859. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.859TTM0.8590.000
TTM0.859YOY0.739+0.120
TTM0.8595Y0.644+0.215
5Y0.64410Y0.654-0.010
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8590.8590.000
TTM0.8590.8590.000
YOY0.7390.739+0.000
5Y0.6440.6440.000
10Y0.6540.651+0.003

1.4. Solvency of Indoco Remedies Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Indoco assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Indoco to Drugs - Generic industry mean.
  • A Debt to Asset Ratio of 0.38 means that Indoco assets are financed with 38.0% credit (debt) and the remaining percentage (100% - 38.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Indoco Remedies Limited:

  • The MRQ is 0.380. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.380. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.380TTM0.3800.000
TTM0.380YOY0.391-0.011
TTM0.3805Y0.425-0.045
5Y0.42510Y0.418+0.007
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3800.484-0.104
TTM0.3800.484-0.104
YOY0.3910.542-0.151
5Y0.4250.544-0.119
10Y0.4180.607-0.189
1.4.2. Debt to Equity Ratio

Measures if Indoco is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Indoco to the Drugs - Generic industry mean.
  • A Debt to Equity ratio of 61.3% means that company has ₹0.61 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Indoco Remedies Limited:

  • The MRQ is 0.613. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.613. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.613TTM0.6130.000
TTM0.613YOY0.643-0.030
TTM0.6135Y0.748-0.136
5Y0.74810Y0.727+0.021
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6130.937-0.324
TTM0.6130.937-0.324
YOY0.6431.181-0.538
5Y0.7481.199-0.451
10Y0.7271.918-1.191

2. Market Valuation of Indoco Remedies Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Indoco generates.

  • Above 15 is considered overpriced but always compare Indoco to the Drugs - Generic industry mean.
  • A PE ratio of 21.09 means the investor is paying ₹21.09 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Indoco Remedies Limited:

  • The EOD is 21.280. Based on the earnings, the company is fair priced.
  • The MRQ is 21.089. Based on the earnings, the company is fair priced.
  • The TTM is 21.089. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD21.280MRQ21.089+0.191
MRQ21.089TTM21.0890.000
TTM21.089YOY22.416-1.326
TTM21.0895Y-98.229+119.318
5Y-98.22910Y-31.884-66.345
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD21.28028.909-7.629
MRQ21.08925.177-4.088
TTM21.08925.177-4.088
YOY22.41622.4160.000
5Y-98.22926.162-124.391
10Y-31.88418.338-50.222
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Indoco Remedies Limited:

  • The EOD is -106.542. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -105.585. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -105.585. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-106.542MRQ-105.585-0.957
MRQ-105.585TTM-105.5850.000
TTM-105.585YOY71.537-177.122
TTM-105.5855Y108.764-214.349
5Y108.76410Y77.521+31.243
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-106.54213.232-119.774
MRQ-105.58513.341-118.926
TTM-105.58513.341-118.926
YOY71.53714.804+56.733
5Y108.76417.113+91.651
10Y77.5214.165+73.356
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Indoco is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drugs - Generic industry mean).
  • A PB ratio of 2.92 means the investor is paying ₹2.92 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Indoco Remedies Limited:

  • The EOD is 2.944. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.918. Based on the equity, the company is underpriced. +1
  • The TTM is 2.918. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.944MRQ2.918+0.026
MRQ2.918TTM2.9180.000
TTM2.918YOY3.836-0.918
TTM2.9185Y3.175-0.258
5Y3.17510Y3.619-0.443
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD2.9442.998-0.054
MRQ2.9182.9180.000
TTM2.9182.9180.000
YOY3.8363.8360.000
5Y3.1753.175+0.000
10Y3.6193.6190.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Indoco Remedies Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--13.41413.4140%14.720-9%7.667+75%11.158+20%
Book Value Per Share--111.584111.5840%98.170+14%87.728+27%75.107+49%
Current Ratio--1.9041.9040%1.821+5%1.538+24%1.496+27%
Debt To Asset Ratio--0.3800.3800%0.391-3%0.425-11%0.418-9%
Debt To Equity Ratio--0.6130.6130%0.643-5%0.748-18%0.727-16%
Dividend Per Share--2.2492.2490%1.497+50%1.123+100%1.431+57%
Eps--15.43715.4370%16.799-8%8.927+73%8.163+89%
Free Cash Flow Per Share---3.083-3.0830%5.264-159%2.713-214%1.077-386%
Free Cash Flow To Equity Per Share---0.609-0.6090%0.449-236%-0.141-77%-0.217-64%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--11.776--------
Intrinsic Value_10Y_min---117.291--------
Intrinsic Value_1Y_max--2.388--------
Intrinsic Value_1Y_min---2.298--------
Intrinsic Value_3Y_max--6.255--------
Intrinsic Value_3Y_min---15.134--------
Intrinsic Value_5Y_max--9.011--------
Intrinsic Value_5Y_min---36.893--------
Market Cap30271406400.000+1%29999562720.00029999562720.0000%34699233120.000-14%25850951712.000+16%24471460224.000+23%
Net Profit Margin--0.0850.0850%0.100-15%0.056+53%0.065+32%
Operating Margin----0%-0%0.039-100%0.078-100%
Operating Ratio--0.3540.3540%0.339+4%0.731-52%1.003-65%
Pb Ratio2.944+1%2.9182.9180%3.836-24%3.175-8%3.619-19%
Pe Ratio21.280+1%21.08921.0890%22.416-6%-98.229+566%-31.884+251%
Price Per Share328.500+1%325.550325.5500%376.550-14%280.530+16%265.560+23%
Price To Free Cash Flow Ratio-106.542-1%-105.585-105.5850%71.537-248%108.764-197%77.521-236%
Price To Total Gains Ratio20.974+1%20.78520.7850%23.219-10%-82.558+497%-26.026+225%
Quick Ratio--0.8590.8590%0.739+16%0.644+33%0.654+31%
Return On Assets--0.0860.0860%0.104-18%0.055+55%0.064+34%
Return On Equity--0.1380.1380%0.171-19%0.092+50%0.107+29%
Total Gains Per Share--15.66215.6620%16.217-3%8.791+78%12.589+24%
Usd Book Value--123389928.000123389928.0000%108556812.000+14%97009725.600+27%83053266.000+49%
Usd Book Value Change Per Share--0.1610.1610%0.177-9%0.092+75%0.134+20%
Usd Book Value Per Share--1.3391.3390%1.178+14%1.053+27%0.901+49%
Usd Dividend Per Share--0.0270.0270%0.018+50%0.013+100%0.017+57%
Usd Eps--0.1850.1850%0.202-8%0.107+73%0.098+89%
Usd Free Cash Flow---3409524.000-3409524.0000%5820624.000-159%3000338.400-214%1190626.800-386%
Usd Free Cash Flow Per Share---0.037-0.0370%0.063-159%0.033-214%0.013-386%
Usd Free Cash Flow To Equity Per Share---0.007-0.0070%0.005-236%-0.002-77%-0.003-64%
Usd Market Cap363256876.800+1%359994752.640359994752.6400%416390797.440-14%310211420.544+16%293657522.688+23%
Usd Price Per Share3.942+1%3.9073.9070%4.519-14%3.366+16%3.187+23%
Usd Profit--17070180.00017070180.0000%18575940.000-8%9871437.600+73%9027186.000+89%
Usd Revenue--200233332.000200233332.0000%184890420.000+8%156622099.200+28%135200546.400+48%
Usd Total Gains Per Share--0.1880.1880%0.195-3%0.105+78%0.151+24%
 EOD+5 -3MRQTTM+0 -0YOY+14 -205Y+27 -810Y+27 -8

3.2. Fundamental Score

Let's check the fundamental score of Indoco Remedies Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1521.280
Price to Book Ratio (EOD)Between0-12.944
Net Profit Margin (MRQ)Greater than00.085
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.859
Current Ratio (MRQ)Greater than11.904
Debt to Asset Ratio (MRQ)Less than10.380
Debt to Equity Ratio (MRQ)Less than10.613
Return on Equity (MRQ)Greater than0.150.138
Return on Assets (MRQ)Greater than0.050.086
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Indoco Remedies Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.242
Ma 20Greater thanMa 50336.893
Ma 50Greater thanMa 100354.599
Ma 100Greater thanMa 200362.375
OpenGreater thanClose335.700
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets16,581,983
Total Liabilities6,299,489
Total Stockholder Equity10,282,494
 As reported
Total Liabilities 6,299,489
Total Stockholder Equity+ 10,282,494
Total Assets = 16,581,983

Assets

Total Assets16,581,983
Total Current Assets8,081,827
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 102,070
Short-term Investments 17,298
Net Receivables 3,509,404
Inventory 3,427,922
Other Current Assets 54,826
Total Current Assets  (as reported)8,081,827
Total Current Assets  (calculated)7,111,520
+/- 970,307
Long-term Assets
Property Plant Equipment 6,675,822
Goodwill 900
Intangible Assets 1,241,787
Long-term Assets  (as reported)0
Long-term Assets  (calculated)7,918,509
+/- 7,918,509

Liabilities & Shareholders' Equity

Total Current Liabilities4,245,091
Long-term Liabilities0
Total Stockholder Equity10,282,494
Total Current Liabilities
Short-term Debt 1,183,710
Total Current Liabilities  (as reported)4,245,091
Total Current Liabilities  (calculated)1,183,710
+/- 3,061,381
Long-term Liabilities
Long term Debt Total 1,585,368
Capital Lease Obligations Min Short Term Debt-1,183,710
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)401,658
+/- 401,658
Total Stockholder Equity
Common Stock184,301
Retained Earnings 9,456,100
Capital Surplus 642,093
Total Stockholder Equity (as reported)10,282,494
Total Stockholder Equity (calculated)10,282,494
+/-0
Other
Cash and Short Term Investments 119,368
Common Stock Shares Outstanding 92,150
Liabilities and Stockholders Equity 16,581,983
Net Working Capital 3,836,736



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
7,294,139
8,455,733
9,405,807
11,967,479
12,379,289
12,580,498
12,715,951
13,150,615
14,860,921
16,581,983
16,581,98314,860,92113,150,61512,715,95112,580,49812,379,28911,967,4799,405,8078,455,7337,294,139
   > Total Current Assets 
3,045,600
3,853,564
4,645,510
5,720,503
5,389,612
5,380,522
5,631,038
6,225,262
7,736,191
8,081,827
8,081,8277,736,1916,225,2625,631,0385,380,5225,389,6125,720,5034,645,5103,853,5643,045,600
       Cash And Cash Equivalents 
133,855
153,985
126,335
625,860
80,032
202,730
379,300
87,868
167,728
102,070
102,070167,72887,868379,300202,73080,032625,860126,335153,985133,855
       Short-term Investments 
0
0
156,798
129,119
17,486
99,770
29,974
10
0
17,298
17,29801029,97499,77017,486129,119156,79800
       Net Receivables 
1,383,970
1,557,055
1,888,339
2,156,777
2,095,059
1,958,372
2,101,439
2,338,238
2,972,446
3,509,404
3,509,4042,972,4462,338,2382,101,4391,958,3722,095,0592,156,7771,888,3391,557,0551,383,970
       Inventory 
1,102,179
1,491,213
1,736,737
1,956,245
2,020,062
1,936,564
2,197,455
2,585,014
3,222,816
3,427,922
3,427,9223,222,8162,585,0142,197,4551,936,5642,020,0621,956,2451,736,7371,491,2131,102,179
       Other Current Assets 
387,624
612,143
102,231
816,264
1,118,290
1,121,694
992,317
1,085,207
1,021,891
54,826
54,8261,021,8911,085,207992,3171,121,6941,118,290816,264102,231612,143387,624
   > Long-term Assets 
0
0
0
6,244,848
6,989,677
7,199,976
7,084,913
0
0
0
0007,084,9137,199,9766,989,6776,244,848000
       Property Plant Equipment 
3,204,886
3,210,298
3,401,867
4,331,315
5,168,866
5,578,466
5,489,455
5,535,308
5,846,626
6,675,822
6,675,8225,846,6265,535,3085,489,4555,578,4665,168,8664,331,3153,401,8673,210,2983,204,886
       Goodwill 
1,192
3,052
3,052
900
900
900
900
900
900
900
9009009009009009009003,0523,0521,192
       Long Term Investments 
1,700
1,700
210
210
0
0
0
0
0
0
0000002102101,7001,700
       Intangible Assets 
489,426
811,830
879,417
973,015
1,074,420
951,425
914,093
845,121
918,781
1,241,787
1,241,787918,781845,121914,093951,4251,074,420973,015879,417811,830489,426
       Long-term Assets Other 
0
0
0
436,910
0
0
-15
0
0
0
000-1500436,910000
> Total Liabilities 
2,720,152
3,267,736
3,640,630
5,454,115
5,629,478
5,974,274
5,920,257
5,460,709
5,814,520
6,299,489
6,299,4895,814,5205,460,7095,920,2575,974,2745,629,4785,454,1153,640,6303,267,7362,720,152
   > Total Current Liabilities 
2,021,463
2,621,217
3,029,519
3,903,870
4,173,612
4,455,012
4,589,864
4,069,199
4,248,536
4,245,091
4,245,0914,248,5364,069,1994,589,8644,455,0124,173,6123,903,8703,029,5192,621,2172,021,463
       Short-term Debt 
919,941
965,431
872,316
1,183,580
1,099,314
1,133,937
1,059,786
1,163,238
1,037,330
1,183,710
1,183,7101,037,3301,163,2381,059,7861,133,9371,099,3141,183,580872,316965,431919,941
       Short Long Term Debt 
919,941
965,431
1,398,233
2,795,369
1,591,478
1,688,376
1,658,752
0
0
0
0001,658,7521,688,3761,591,4782,795,3691,398,233965,431919,941
       Accounts payable 
706,611
1,198,556
1,313,111
1,640,293
1,495,497
1,707,227
1,656,037
0
0
0
0001,656,0371,707,2271,495,4971,640,2931,313,1111,198,556706,611
       Other Current Liabilities 
466,291
517,840
527,793
579,347
753,452
798,386
986,431
0
0
0
000986,431798,386753,452579,347527,793517,840466,291
   > Long-term Liabilities 
0
0
0
1,616,074
1,455,858
1,519,262
1,330,393
0
0
0
0001,330,3931,519,2621,455,8581,616,074000
       Long term Debt Total 
0
0
378,853
1,323,097
1,232,759
1,286,571
1,024,211
1,039,444
1,068,472
1,585,368
1,585,3681,068,4721,039,4441,024,2111,286,5711,232,7591,323,097378,85300
       Capital Lease Obligations 
0
0
0
0
0
0
60,085
0
0
0
00060,085000000
       Long-term Liabilities Other 
0
0
0
44,467
0
-1
1
0
0
0
0001-1044,467000
> Total Stockholder Equity
4,571,507
5,187,997
5,765,177
6,513,364
6,749,811
6,606,224
6,795,694
7,689,906
9,046,401
10,282,494
10,282,4949,046,4017,689,9066,795,6946,606,2246,749,8116,513,3645,765,1775,187,9974,571,507
   Common Stock
184,301
184,301
184,301
184,301
184,301
184,301
184,301
184,301
184,301
184,301
184,301184,301184,301184,301184,301184,301184,301184,301184,301184,301
   Retained Earnings 
3,751,587
4,356,642
4,937,314
5,687,010
5,923,451
5,779,830
5,969,300
6,863,512
8,220,007
9,456,100
9,456,1008,220,0076,863,5125,969,3005,779,8305,923,4515,687,0104,937,3144,356,6423,751,587
   Accumulated Other Comprehensive Income 0000000000
   Capital Surplus 
0
0
644,195
642,093
642,093
642,093
642,093
642,093
642,093
642,093
642,093642,093642,093642,093642,093642,093642,093644,19500
   Treasury Stock0000000000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue16,686,111
Cost of Revenue-5,899,261
Gross Profit10,786,85010,786,850
 
Operating Income (+$)
Gross Profit10,786,850
Operating Expense-0
Operating Income2,169,42610,786,850
 
Operating Expense (+$)
Research Development0
Selling General Administrative6,708,640
Selling And Marketing Expenses0
Operating Expense06,708,640
 
Net Interest Income (+$)
Interest Income229,222
Interest Expense-0
Other Finance Cost-229,222
Net Interest Income0
 
Pretax Income (+$)
Operating Income2,169,426
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,927,9212,169,426
EBIT - interestExpense = 0
1,422,515
1,422,515
Interest Expense0
Earnings Before Interest and Taxes (EBIT)01,927,921
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,927,921
Tax Provision-505,406
Net Income From Continuing Ops01,422,515
Net Income1,422,515
Net Income Applicable To Common Shares1,422,515
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net00
 

Technical Analysis of Indoco
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Indoco. The general trend of Indoco is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Indoco's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Indoco Remedies Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 380.00 < 380.00 < 385.10.

The bearish price targets are: 320.00 > 319.55 > 315.75.

Tweet this
Indoco Remedies Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Indoco Remedies Limited. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Indoco Remedies Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Indoco Remedies Limited. The current macd is -7.12571608.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Indoco price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Indoco. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Indoco price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Indoco Remedies Limited Daily Moving Average Convergence/Divergence (MACD) ChartIndoco Remedies Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Indoco Remedies Limited. The current adx is 15.75.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Indoco shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Indoco Remedies Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Indoco Remedies Limited. The current sar is 321.18.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Indoco Remedies Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Indoco Remedies Limited. The current rsi is 39.24. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Indoco Remedies Limited Daily Relative Strength Index (RSI) ChartIndoco Remedies Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Indoco Remedies Limited. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Indoco price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Indoco Remedies Limited Daily Stochastic Oscillator ChartIndoco Remedies Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Indoco Remedies Limited. The current cci is -82.50955582.

Indoco Remedies Limited Daily Commodity Channel Index (CCI) ChartIndoco Remedies Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Indoco Remedies Limited. The current cmo is -23.45833643.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Indoco Remedies Limited Daily Chande Momentum Oscillator (CMO) ChartIndoco Remedies Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Indoco Remedies Limited. The current willr is -72.97297297.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Indoco is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Indoco Remedies Limited Daily Williams %R ChartIndoco Remedies Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Indoco Remedies Limited.

Indoco Remedies Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Indoco Remedies Limited. The current atr is 12.78.

Indoco Remedies Limited Daily Average True Range (ATR) ChartIndoco Remedies Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Indoco Remedies Limited. The current obv is 170,650.

Indoco Remedies Limited Daily On-Balance Volume (OBV) ChartIndoco Remedies Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Indoco Remedies Limited. The current mfi is 51.71.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Indoco Remedies Limited Daily Money Flow Index (MFI) ChartIndoco Remedies Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Indoco Remedies Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Indoco Remedies Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Indoco Remedies Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.242
Ma 20Greater thanMa 50336.893
Ma 50Greater thanMa 100354.599
Ma 100Greater thanMa 200362.375
OpenGreater thanClose335.700
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Indoco with someone you think should read this too:
  • Are you bullish or bearish on Indoco? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Indoco? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Indoco Remedies Limited

I send you an email if I find something interesting about Indoco Remedies Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Indoco Remedies Limited.

Receive notifications about Indoco Remedies Limited in your mailbox!